Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
Gareth Pryce(National Hospital for Neurology and Neurosurgery), David Baker(Quadram Institute), Zubair Ahmed(University of Birmingham), Axel Petzold(University College London), Alan J. Thompson(Queen Mary University of London), Jennifer M. Pocock(National Hospital for Neurology and Neurosurgery), Deborah J.R. Hankey(University College London), Samuel J. Jackson(Queen Mary University of London), J. Ludovic Croxford(Monash University), Gavin Giovannoni(Queen Mary University of London), M. L. Cuzner(University College London), Catherine Ledent(Université Libre de Bruxelles)
Cited by 341
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k